Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Zevaskynzevaskyn.comZEVASKYN is a personalized gene therapy made from a patient's own skin cells, designed to deliver long-lasting wound healing for recessive dystrophic epidermolysis bullosa (RDEB). In a clinical trial, 81% of ZEVASKYN-treated wounds healed by 50% or more at six months, compared to 16% of matched control wounds.
Parse Score
